Adam R. Craig
Adam R. Craig has made 1 open-market purchase worth $12k since Oct 19, 2026, in 1 company. The latest: $12k of XFOR, filed Oct 19, 2026, scored 32 out of 100.
Chair, X4 Pharmaceuticals, Inc
Follow Adam R. Craig, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Purchases
| Filed | Stock | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 19 Form 4 (opens sec.gov) |
XFORX4 Pharmaceuticals, Inc · ChairChair · Near 52-week low | +1% stake | 32 | $12k 4,600 at $2.58 |
— | — |
Questions
What stock has Adam R. Craig bought?
XFOR (X4 Pharmaceuticals, Inc), all on the open market and reported on SEC Form 4.
When did Adam R. Craig last buy?
Oct 19, 2026: 4,600 shares of XFOR at $2.58, $12k in all (Form 4 (opens sec.gov)).
Has Adam R. Craig filed a notice of a planned sale?
Not in the filings on record. A Form 144 is the notice an insider must file before selling restricted or control shares, and it lands on EDGAR before the sale is reported.
Is Adam R. Craig a routine or an opportunistic buyer?
There isn't enough history to say yet.
Data as of Oct 19, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer